Recombinant human interferon-beta for condylomata acuminata: a randomized, double-blind, placebo-controlled study of intralesional therapy.
Bornstein, J
Recombinant human interferon-beta for condylomata acuminata: a randomized, double-blind, placebo-controlled study of intralesional therapy. [electronic resource] - International journal of STD & AIDS Oct 1997 - 614-21 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0956-4624
10.1258/0956462971918878 doi
Adolescent
Adult
Biopsy
Condylomata Acuminata--pathology
DNA, Viral--analysis
Double-Blind Method
Female
Humans
Injections, Intralesional
Interferon beta-1a
Interferon-beta--therapeutic use
Male
Middle Aged
Papillomaviridae--genetics
Treatment Outcome
Recombinant human interferon-beta for condylomata acuminata: a randomized, double-blind, placebo-controlled study of intralesional therapy. [electronic resource] - International journal of STD & AIDS Oct 1997 - 614-21 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0956-4624
10.1258/0956462971918878 doi
Adolescent
Adult
Biopsy
Condylomata Acuminata--pathology
DNA, Viral--analysis
Double-Blind Method
Female
Humans
Injections, Intralesional
Interferon beta-1a
Interferon-beta--therapeutic use
Male
Middle Aged
Papillomaviridae--genetics
Treatment Outcome